Charles Cherington

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Charles Cherington
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Cherington:

Company Role Class Num Shares Value Price $ Report Date Ownership
Comera Life Sciences Holdings, Inc. 10%+ Owner Warrants to Purchase Common Stock 20,650,908 $5,162,727 $0.2500 29 Dec 2023 Direct
Ernexa Therapeutics Inc. 10%+ Owner Common Stock 41,659,743 $4,357,609 $0.1046 09 Jun 2025 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock 5,813,650 $411,606 $0.0708 11 Sep 2023 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock 1,268,761 $89,828 $0.0708 11 Sep 2023 By LLC
Comera Life Sciences Holdings, Inc. 10%+ Owner Common Stock 95,328 $6,749 $0.0708 11 Sep 2023 By trust
Eterna Therapeutics Inc. 10%+ Owner Warrants (right to buy) 0 $0 $0.1250 29 Oct 2024 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner Series A Convertible Perpetual Preferred Stock 3,896 27 Dec 2023 By LLC
Eterna Therapeutics Inc. 10%+ Owner 12.0% Senior Convertible Notes due December 12, 2028 0 29 Oct 2024 Direct
Eterna Therapeutics Inc. 10%+ Owner 12.0% Senior Convertible Notes due September 24, 2025 0 29 Oct 2024 Direct
Eterna Therapeutics Inc. 10%+ Owner 6.0% Senior Convertible Promissory Notes due 2028 0 29 Oct 2024 Direct
Comera Life Sciences Holdings, Inc. 10%+ Owner 12.0% Senior Secured Convertible Notes $567,900 29 Dec 2023 Direct

Insider Reports Filed by Charles Cherington

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ERNA Ernexa Therapeutics Inc. 09 Jun 2025 1 +$2,221,826 4 10%+ Owner 11 Jun 2025, 20:34
ERNA Eterna Therapeutics Inc. 02 Apr 2025 1 +$394,174 4 10%+ Owner 04 Apr 2025, 10:54
ERNA Ernexa Therapeutics Inc. 24 Sep 2024 10 -$6,540,000 4/A 10%+ Owner 07 May 2025, 11:48
ERNA Eterna Therapeutics Inc. 23 Sep 2024 17 -$4,890,227 4 10%+ Owner 05 Nov 2024, 12:42
/report/000110465924001041-cherington-charles-2023-12-27 Comera Life Sciences Holdings, Inc. 27 Dec 2023 3 +$1,948,332,900 4 10%+ Owner 03 Jan 2024, 20:38
ERNA Eterna Therapeutics Inc. 14 Dec 2023 6 +$3,390,747 4 10%+ Owner 20 Dec 2023, 10:05
/report/000110465923099800-cherington-charles-2023-09-11 Comera Life Sciences Holdings, Inc. 11 Sep 2023 2 +$1,049,897 4 10%+ Owner 11 Sep 2023, 21:24
/report/000110465923095433-cherington-charles-2023-07-31 Comera Life Sciences Holdings, Inc. 31 Jul 2023 2 +$450,044 4 10%+ Owner 25 Aug 2023, 20:33
ERNA Eterna Therapeutics Inc. 13 Jul 2023 2 +$3,588,462 4 10%+ Owner 25 Aug 2023, 20:34
/report/000089924323001182-cherington-charles-2023-01-04 Comera Life Sciences Holdings, Inc. 04 Jan 2023 2 +$1,100,000 4 10%+ Owner 06 Jan 2023, 15:45
ERNA Eterna Therapeutics Inc. 02 Dec 2022 2 +$923,999 4 Director, 10%+ Owner 06 Dec 2022, 20:02
/report/000106299322021051-cherington-charles-2022-10-20 Comera Life Sciences Holdings, Inc. 20 Oct 2022 2 +$23,680 4 10%+ Owner 24 Oct 2022, 16:03
/report/000106299322020905-cherington-charles-2022-10-14 Comera Life Sciences Holdings, Inc. 14 Oct 2022 2 +$32,167 4 10%+ Owner 18 Oct 2022, 16:04
/report/000106299322020800-cherington-charles-2022-10-13 Comera Life Sciences Holdings, Inc. 13 Oct 2022 1 +$17,387 4 10%+ Owner 14 Oct 2022, 16:03
/report/000106299322020096-cherington-charles-2022-09-29 Comera Life Sciences Holdings, Inc. 29 Sep 2022 1 +$33,477 4 10%+ Owner 30 Sep 2022, 16:04
/report/000106299322020051-cherington-charles-2022-09-27 Comera Life Sciences Holdings, Inc. 27 Sep 2022 1 +$20,221 4 10%+ Owner 29 Sep 2022, 16:02
ERNA Brooklyn ImmunoTherapeutics, Inc. 01 Aug 2022 2 $0 4 Director 03 Aug 2022, 20:01
/report/000089924322031081-cherington-charles-2022-05-19 Comera Life Sciences Holdings, Inc. 19 May 2022 0 $0 3 10%+ Owner 14 Sep 2022, 20:04
ERNA Brooklyn ImmunoTherapeutics, Inc. 08 Dec 2021 2 $0 4 Director 10 Dec 2021, 20:00
/report/000089924321045933-cherington-charles-2021-11-23 Beard Energy Transition Acquisition Corp. 23 Nov 2021 0 $0 3 Director 23 Nov 2021, 20:10
ERNA Brooklyn ImmunoTherapeutics, Inc. 16 Jun 2021 3 -$6,296,568 4 Director, 10%+ Owner 21 Jun 2021, 18:00